A Within Subjects Comparison of Two Antegrade Flushing Regimens in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 9, 2016

Primary Completion Date

March 28, 2017

Study Completion Date

March 30, 2018

Conditions
Fecal IncontinenceNeurogenic Bowel
Interventions
DRUG

Dose Response - NS and USP Glycerin - First Intervention

This trial used a repeated measures, single subjects alternating treatments A-B-C-B'-C'-B1' withdrawal design in which all subjects were tested under all conditions and each subject acted as his or her own control. The subjects were randomly assigned to either normal saline or USP glycerin to control for order effects. Baseline data A served as the control and was obtained pre-operatively. The B-C arm evaluated dose-response relationship and was used to identify the minimum dosing volume and frequency of ACE administration of NS and USP Glycerin necessary to promote fecal continence. When the optimal dose as identified, the child continued on that dose for 2 weeks to insure treatment stability and effectiveness.

DRUG

Effectiveness - NS and USP Glycerin - Second Intervention

To prevent statistical bias from subject loss due to treatment failure, each child was randomized to a second treatment sequence once they have achieved continence with minimal side effects on optimal dosing The second phase B'-C'-B1' of the study compared the two regimens at optimal dose and administration frequency. This phase was used to confirm the effectiveness of NS and USP Glycerin at optimal dosing on continence and assess side effects.

Trial Locations (1)

32207

Nemours Children's Specialty Clinic, Jacksonville

All Listed Sponsors
collaborator

University of Florida

OTHER

lead

Nemours Children's Clinic

OTHER

NCT02435069 - A Within Subjects Comparison of Two Antegrade Flushing Regimens in Children | Biotech Hunter | Biotech Hunter